Bigorra J, Baños J E
Medical Department, Química-Farmacéutica Bayer, Barcelona, Spain.
Eur J Clin Pharmacol. 1990;38(5):443-6. doi: 10.1007/BF02336681.
The aim of this survey was twofold: to assess the willingness of medical students to volunteer for clinical trials and to evaluate the weight of the financial reward and other general details as seen by healthy volunteers who had already participated in clinical trials. A specific questionnaire was given to each group to be answered anonymously. Among the medical students only 2.9% had already volunteered, 39.7% said that they would never participate, 24.7% would do it for scientific interest, 32.2% for scientific interest and financial reward, and 4.2% for the financial reward alone. In experienced volunteers, financial reward was the main reason to participate (90%) followed by curiosity (6.3%). The financial reward actually received was considered adequate compensation for the time and discomfort by most of the volunteers (83.7%). The information supplied by the research team and the arrangements made to treat any hazardous event were considered adequate (47.5%) or optimal (42.5%). Almost all the experienced volunteers (93.8%) answered positively when asked about participation in future studies. The results show that financial reward is a very important reason for healthy volunteers to participate in clinical trials.
评估医学生参与临床试验的意愿,以及评估经济奖励的分量和已参与临床试验的健康志愿者所看重的其他一般细节。向每个组发放了一份特定问卷,要求匿名作答。在医学生中,只有2.9%的人已经参与过志愿活动,39.7%的人表示他们永远不会参与,24.7%的人会出于科学兴趣参与,32.2%的人会出于科学兴趣和经济奖励参与,还有4.2%的人仅为了经济奖励参与。在有经验的志愿者中,经济奖励是参与的主要原因(90%),其次是好奇心(6.3%)。大多数志愿者(83.7%)认为实际获得的经济奖励足以补偿时间和不适。研究团队提供的信息以及为处理任何危险事件所做的安排被认为是足够的(47.5%)或最佳的(42.5%)。当被问及是否愿意参与未来的研究时,几乎所有有经验的志愿者(93.8%)都给出了肯定回答。结果表明,经济奖励是健康志愿者参与临床试验的一个非常重要的原因。